Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What CAGR And Valuation Are Anticipated For The Gene Expression Market?

In recent years, the gene expression market size has seen a robust growth. It is projected to increase from $11.55 billion in 2024 to $12.67 billion in 2025, with a compound annual growth rate (CAGR) of 9.7%. This growth during the historical period can be credited to factors such as greater emphasis on precision medicine, a surge in cancer research and biomarker discovery, its use in disease diagnosis and prognosis, incorporation with systems biology approaches, and requirements of drug discovery and development.

The market size for gene expression is predicted to experience significant expansion in the coming years. It’s projected to reach a market cap of $19.81 billion by 2029, growing at a compound annual growth rate (CAGR) of 11.8%. The expected growth during the forecast period can be attributed to various factors such as the emergence of spatial transcriptomics, an increase in epigenomic research, global health incidents and planning for pandemics, emphasis on the exploration of non-coding RNA, and increased usage in immunotherapy research. Some of the major projected trends for this period encompass single-cell RNA sequencing, advancements in next-gen sequencing, the integration of multi-omics data, progress in gene editing technologies, development of liquid biopsy, and the use of spatial omics in drug discovery.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9156&type=smp

Which Demand Drivers Are Strengthening The Gene Expression Market?

The growth of the gene expression market is expected to be fueled by the intensified focus on precision medicine. Precision medicine uses the understanding of a person’s genomic information or proteins to diagnose, prevent and formulate the appropriate treatment of a disease. The technology of gene expression plays a critical role in precision medicine, as it helps in identifying abnormalities and monitors normal function and physiologic regulation in an individual. It accomplishes this by measuring and comparing genes and transcripts in various tissues under different medical conditions. This method guides more patient-focused treatment protocols. For example, a report from the Personalized Medicine Coalition, a non-profit organization based in the US, in February 2023, stated that personalized medicines accounted for 35% of the newly approved NMEs in 2021. Plus, with 12 additional approvals in 2022, these medications have sustained a steady share of at least 25% of new drug approvals over the last eight years. This shows a considerable increase from less than 10% just ten years ago. Hence, this growing emphasis on precision medicine is significantly affecting the progression of the gene expression market.

What Are The Primary Segmentation Parameters In The Gene Expression Market?

The gene expression market covered in this report is segmented –

1) By Product: Kits And Reagents, DNA Chip Or Microarray, Other Products

2) By Process: Sample Collection, Purification, cDNA Synthesis And Conversion, PCR Analysis, Data Analysis And Interpretation

3) By Technique: RNA Exp, Promoter Analysis, Protein Exp. And Posttranslational Modification Analysis

4) By Application: Drug Discovery And Development, Clinical Diagnostics, Biotechnology And Microbiology, Other Applications

Subsegments:

1) By Kits And Reagents: RNA Isolation Kits, cDNA Synthesis Kits, qPCR Kits, Reverse Transcription Kits, Other Reagents

2) By DNA Chip Or Microarray: Expression Microarrays, Genotyping Microarrays, Comparative Genomic Hybridization Arrays,

3) By Other Products: Software For Data Analysis, Lab Instruments, Consumables

Which Emerging Trends Are Reshaping The Gene Expression Market Landscape?

A primary trend in the gene expression market is the progression in technology. Leading companies in the sector are increasingly adopting the RNA gene expression technology. To illustrate, Enzo Biochem, Inc., a biosciences and diagnostics giant hailing from the U.S., introduced AMPIVIEW in September 2022. This new platform is innovatively devised for enhanced sensitivity in detecting and visualizing biomarkers in cellular and tissue samples. AMPIVIEW uses in-situ hybridization technology for the identification of HPV and SARS-CoV-2, and offers a precise and sensitive discovery method for target genes in tissues or cells, while keeping the morphology preserved.

Which Players Are Shaping The Competitive Landscape Of The Gene Expression Market?

Major companies operating in the gene expression market include Thermo Fisher Scientific Inc., Qiagen NV, Illumina Inc., Bio-Rad Laboratories Inc., Agilent Technologies Inc., PerkinElmer Inc., GE Healthcare, F Hoffmann-La Roche Ltd, Oxford Gene Technology IP Limited, Promega Corporation, OriGene Technologies Inc., Luminex Corporation, Takara Bio Inc., Danaher Corporation, ELITechGroup, Biocartis Group NV, Integragen SA, Oxford Nanopore Technologies Limited, Phalanx Biotech Group, Roche Holding AG, Sengenics Corporation Pte Ltd., GenXPro GmbH, Twist Bioscience Corporation, Zymo Research Corporation, Abcam plc., Bio-Techne Corporation

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/gene-expression-global-market-report

What Are The Emerging Regional Trends Driving The Gene Expression Market?

North America was the largest region in the gene expression market in 2024. Asia-Pacific is expected to be the fastest-growing region in the gene expression market in the forecast period. The regions covered in the gene expression market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=9156&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model